HCI Group, Inc.·4

Feb 24, 4:30 PM ET

Patel Paresh 4

4 · HCI Group, Inc. · Filed Feb 24, 2026

Research Summary

AI-generated summary of this filing

Updated

HCI Group (HCI) CEO Paresh Patel Exercises Options

What Happened

  • Paresh Patel, CEO of HCI Group, exercised options to acquire 20,000 shares at $40.00 per share (total cost $800,000) on February 23, 2026. The same day the filing records a disposition of 20,000 derivative shares at $40.00 per share (total $800,000).
  • This filing reports an option exercise (code M) paired with a derivative disposition; it is not an open-market purchase. The filing itself does not state whether the disposed shares were the same shares immediately sold, used to cover the exercise cost, or otherwise transferred.

Key Details

  • Transaction date: February 23, 2026; Form 4 filed February 24, 2026 (timely).
  • Exercise/acquisition: 20,000 shares @ $40.00 = $800,000 (code M).
  • Disposition: 20,000 derivative shares @ $40.00 = $800,000 (reported as a derivative disposal).
  • Shares owned after transaction: not specified in the provided excerpt of the filing.
  • Relevant footnotes: F1 (shares held jointly with spouse); F3–F5 note options were granted under HCI's 2012 Omnibus Incentive Plan and include $40.00 exercise-price grants (Jan 7, 2017 and Feb 8, 2018) with vesting/expiration details.
  • Filing does not indicate a 10b5-1 plan, tax withholding, or that the transaction was part of a pre-arranged sale plan.

Context

  • Code M denotes an exercise or conversion of a derivative security (options). The paired acquisition and disposition at the same price often reflects an exercise with a simultaneous sale or transfer, but the Form 4 here doesn’t specify the mechanics.
  • Exercises are not the same signal as an open-market buy by an insider — they show option holders converting contracts into shares (sometimes followed by sale). Retail investors should note purchases are usually clearer bullish signals; an exercise plus immediate disposition can be routine or for liquidity/tax purposes and does not necessarily indicate a change in insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-23
Patel Paresh
DirectorChief Executive Officer10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-23$40.00/sh+20,000$800,00089,500 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F3][F4]
    2026-02-23$40.00/sh20,000$800,00090,000 total
    Exercise: $40.00Exp: 2027-01-07Common (20,000 underlying)
Holdings
  • Common Stock

    (indirect: By IRA)
    37,500
  • Common Stock

    [F1]
    727,000
  • Common Stock

    [F2]
    10,000
  • Common Stock

    [F9]
    200,000
  • Stock Option (Right to Buy)

    [F3][F5]
    Exercise: $40.00Exp: 2028-02-08Common (110,000 underlying)
    110,000
  • Stock Option (Right to Buy)

    [F3][F6]
    Exercise: $53.00Exp: 2029-01-15Common (110,000 underlying)
    110,000
  • Stock Option (Right to Buy)

    [F3][F7]
    Exercise: $48.00Exp: 2030-01-16Common (110,000 underlying)
    110,000
  • Stock Option (Right to Buy)

    [F3][F8]
    Exercise: $70.00Exp: 2033-09-15Common (150,000 underlying)
    150,000
Footnotes (9)
  • [F1]Shares held jointly with spouse.
  • [F2]Restricted stock grant of 10,000 shares effective 2/26/2021: Restricted shares will vest, if ever, on the first anniversary of the date on which the company stock value first equals or exceeds $140 for 30 consecutive days on the applicable exchange. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.
  • [F3]The options were granted pursuant to the HCI Group, Inc. 2012 Omnibus Incentive Plan.
  • [F4]The options were granted on January 7, 2017 at an exercise price of $40.00 per share, in excess of the $39.71 market value. All options have vested and may be exercised at any time up to and including January 7, 2027.
  • [F5]The options were granted on February 8, 2018 at an exercise price of $40.00 per share, in excess of the $34.92 market value. All options have vested and may be exercised at any time up to and including February 8, 2028.
  • [F6]The options were granted on January 15, 2019 at an exercise price of $53.00 per share, in excess of the $47.94 market value. All options have vested and may be exercised at any time up to and including January 15, 2029.
  • [F7]The options were granted on January 16, 2020 at an exercise price of $48.00 per share, in excess of the $45.97 market value. All options have vested and may be exercised at any time up to and including January 16, 2030.
  • [F8]The options were granted on September 15, 2023 and vested on December 14, 2023 at an exercise price of $70.00 per share when the company stock value first equaled and exceeded $80.00 for 20 consecutive days on the applicable exchange. The options will expire on September 15, 2033.
  • [F9]Restricted stock grant of 200,000 shares effective 4/17/2024: If at any time the Fair Market Value equals or exceeds $200 for 30 consecutive trading days (the "Vesting Trigger Date"), the restricted shares will vest and the restrictions will lapse as follows. 50,000 of the restricted shares on the later of the Vesting Trigger Date or March 15, 2025; March 15, 2026; March 15, 2027; and March 15, 2028. No portion of the restriction period will lapse six years and one day after the grant date. All remaining restricted shares will be forfeited at that time. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 4/17/2024.
Signature
/s/ Andrew L. Graham as Attorney-in-fact for Paresh Patel|2026-02-24

Documents

1 file
  • 4
    ownership.xmlPrimary

    4